Related Experiment Video
Updated: Mar 4, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation
Rosa Drago-Ferrante1, Francesca Pentimalli2, Daniela Carlisi3
1Laboratory of Biochemistry, Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Polyclinic, Palermo, Italy.
Abstract:
MiR-29 family dysregulation occurs in various cancers including breast cancers. We investigated miR-29b-1 functional role in human triple negative breast cancer (TNBC) the most aggressive breast cancer subtype. We found that miR-29b-1-5p was downregulated in human TNBC tissues and cell lines. To assess whether miR-29b-1-5p correlated with TNBC regenerative potential, we evaluated cancer stem cell enrichment in our TNBC cell lines, and found that only MDA-MB-231 and BT-20 produced primary, secondary and tertiary mammospheres, which were progressively enriched in OCT4, NANOG and SOX2 stemness genes. MiR-29b-1-5p expression inversely correlated with mammosphere stemness potential, and miR-29b-1 ectopic overexpression decreased TNBC cell growth, self-renewal, migration, invasiveness and paclitaxel resistance repressing WNT/βcatenin and AKT signaling pathways and stemness regulators. We identified SPINDLIN1 (SPIN1) among predicted miR-29b-1-5p targets. Consistently, SPIN1 was overexpressed in most TNBC tissues and cell lines and negatively correlated with miR-29b-1-5p. Target site inhibition showed that SPIN1 seems to be directly controlled by miR-29b-1-5p. Silencing SPIN1 mirrored the effects triggered by miR-29b-1 overexpression, whereas SPIN1 rescue by SPIN1miScript protector, determined the reversal of the molecular effects produced by the mimic-miR-29b-1-5p. Overall, we show that miR-29b-1 deregulation impacts on multiple oncogenic features of TNBC cells and their renewal potential, acting, at least partly, through SPIN1, and suggest that both these factors should be evaluated as new possible therapeutic targets against TNBC.
Insights
MicroRNA-29b-1-5p (miR-29b-1-5p) is downregulated in aggressive triple-negative breast cancer (TNBC). Restoring miR-29b-1-5p suppresses TNBC growth, stemness, and paclitaxel resistance by targeting SPINDLIN1 (SPIN1).
Area of Science:
- Molecular Oncology
- Cancer Stem Cell Biology
- Gene Regulation
Background:
- Dysregulation of the miR-29 family is implicated in various cancers, including breast cancer.
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic options.
- Cancer stem cells (CSCs) contribute to tumor initiation, progression, and treatment resistance in TNBC.
Purpose of the Study:
- To investigate the functional role of miR-29b-1 in human triple-negative breast cancer (TNBC).
- To determine the correlation between miR-29b-1-5p expression and TNBC stem cell potential.
- To elucidate the molecular mechanisms underlying miR-29b-1's tumor-suppressive functions in TNBC.
Main Methods:
- Quantitative real-time PCR to assess miR-29b-1-5p expression in TNBC tissues and cell lines.
- Mammosphere assays to evaluate cancer stem cell enrichment and self-renewal capacity.
- Western blotting and luciferase reporter assays to confirm target gene interactions (SPIN1) and pathway analysis (WNT/β-catenin, AKT).
Main Results:
- miR-29b-1-5p was significantly downregulated in human TNBC tissues and cell lines.
- Reduced miR-29b-1-5p expression correlated with increased mammosphere formation and stemness gene (OCT4, NANOG, SOX2) enrichment.
- Ectopic miR-29b-1-5p overexpression suppressed TNBC cell growth, self-renewal, migration, invasiveness, and paclitaxel resistance, partly via repression of SPINDLIN1 (SPIN1) and WNT/AKT pathways.
Conclusions:
- miR-29b-1 deregulation contributes to multiple oncogenic features and renewal potential in TNBC cells.
- The tumor-suppressive role of miR-29b-1-5p is mediated, at least partly, through the regulation of SPINDLIN1 (SPIN1).
- miR-29b-1 and SPINDLIN1 represent potential novel therapeutic targets for TNBC treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Negative Regulator Molecules
Destabilization of Microtubules
Experimental RNAi

